摘要
目的观察扶正化瘀胶囊结合拉米夫定治疗乙肝后肝硬化的临床疗效。方法治疗组22例采用扶正化瘀胶囊结合拉米夫定治疗,对照组26例以复方益肝灵或护肝片治疗,疗程均为6个月。观察临床症状、肝功能、HBV-DNA载量、血清HA、LN、PCⅢ、Ⅳ-C、超声多普勒检测门静脉直径及血流速、脾静脉直径等变化。结果治疗组与对照组各项检测指标比较均存在显著性差异,治疗组疗效显著。结论扶正化瘀胶囊结合拉米夫定治疗乙肝后肝硬化疗效确切。
Objective To observe the clinical effects of " Fuzheng Huayu Capsule" and Lamivudine in treating posthepatitic cirrhosis. Methods Twenty-two cases in treatment group were treated with "Fuzheng Huayu Capsule" and Lamivudine and 26 cases in control group were treated with "Fufang Yiganling" and "Hugan Tablet" ; the clinical efficacy, liver function, HBV-DNA load, serum HA, LNPC Ⅲ, Ⅳ-C, diameter and blood flow of portal vein, and splenic vein diameter were observed. Results All effects were better in treatment group than in control group. Conclusion "Fuzheng Huayu Capsule" and Lamivudine is safe and effective for posthepatitic cirrhosis.
出处
《上海中医药杂志》
2009年第3期32-33,共2页
Shanghai Journal of Traditional Chinese Medicine
关键词
扶正化瘀胶囊
拉米夫定
复方益肝灵
护肝片
乙型肝炎
肝硬化
"Fuzheng Huayu Capsule"
Lamivudine
"Fufang Yiganling"
" Hugan Tablet"
hepatitis B
cirrhosis